Safety, Tolerability, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder for Pulmonary Hypertension: A Phase 1, Randomized, Double-Blind, Single- and Multiple-Dose Study

INTRODUCTION: Treprostinil is a prostacyclin vasodilator widely used for the treatment of pulmonary arterial hypertension (PAH) and, in its inhaled form, for pulmonary hypertension associated with interstitial lung disease (PH-ILD). Treprostinil palmitil inhalation powder (TPIP) is a dry powder form...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismat, Fraz A., Usansky, Helen H., Villa, Raul, Zou, Jun, Teper, Ariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525339/
https://www.ncbi.nlm.nih.gov/pubmed/36070132
http://dx.doi.org/10.1007/s12325-022-02296-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525339/
https://www.ncbi.nlm.nih.gov/pubmed/36070132
http://dx.doi.org/10.1007/s12325-022-02296-x

Ejemplares similares